Healthcare provider profile · identity verified

Michael W Johnston, M.D.

Family Practice · PHENIX CITY, AL · NPI 1043250327

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	541	156
Albuterol Sulfate Hfa	Albuterol Sulfate	358	102
Amlodipine Besylate	Amlodipine Besylate	345	90
Omeprazole	Omeprazole	343	95
Lisinopril	Lisinopril	280	70
Meloxicam	Meloxicam	262	81
Metformin Hcl	Metformin Hcl	262	72
Carvedilol	Carvedilol	258	67
Levothyroxine Sodium	Levothyroxine Sodium	242	59
Hydrochlorothiazide	Hydrochlorothiazide	175	50
Gabapentin	Gabapentin	166	55
Potassium Chloride	Potassium Chloride	163	49
Trulicity	Dulaglutide	163	25
Furosemide	Furosemide	158	52
Spironolactone	Spironolactone	154	38
Losartan Potassium	Losartan Potassium	145	37
Candesartan Cilexetil	Candesartan Cilexetil	142	34
Pravastatin Sodium	Pravastatin Sodium	131	34
Pantoprazole Sodium	Pantoprazole Sodium	127	35
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	123	36
Allopurinol	Allopurinol	113	30
Metoprolol Succinate	Metoprolol Succinate	110	25
Clopidogrel	Clopidogrel Bisulfate	106	24
Pioglitazone Hcl	Pioglitazone Hcl	106	29
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	100	31
Metoprolol Tartrate	Metoprolol Tartrate	95	29
Tamsulosin Hcl	Tamsulosin Hcl	86	29
Trazodone Hcl	Trazodone Hcl	85	25
Ozempic	Semaglutide	84	20
Alendronate Sodium	Alendronate Sodium	83	23
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	80	21
Simvastatin	Simvastatin	80	22
Ibuprofen	Ibuprofen	76	26
Rosuvastatin Calcium	Rosuvastatin Calcium	69	17
Glipizide	Glipizide	68	17
Amoxicillin	Amoxicillin	66	53
Atenolol	Atenolol	64	17
Hydrocortisone	Hydrocortisone	64	28
Jardiance	Empagliflozin	64	19
Enalapril Maleate	Enalapril Maleate	62	14
Nifedipine Er	Nifedipine	62	18
Levofloxacin	Levofloxacin	60	44
Clonidine Hcl	Clonidine Hcl	58	18
Montelukast Sodium	Montelukast Sodium	57	14
Eliquis	Apixaban	55	14
Humalog Kwikpen U-100	Insulin Lispro	51	16
Meclizine Hcl	Meclizine Hcl	50	13
Prednisone	Prednisone	50	32
Breo Ellipta	Fluticasone/Vilanterol	48	12
Naproxen	Naproxen	45	12
Mounjaro	Tirzepatide	43	suppressed
Famotidine	Famotidine	41	12
Farxiga	Dapagliflozin Propanediol	41	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	40	suppressed
Diclofenac Sodium	Diclofenac Sodium	39	14
Finasteride	Finasteride	37	suppressed
Sertraline Hcl	Sertraline Hcl	37	11
Tramadol Hcl	Tramadol Hcl	36	11
Chlorthalidone	Chlorthalidone	35	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	34	34
Mirtazapine	Mirtazapine	34	suppressed
Symbicort	Budesonide/Formoterol Fumarate	34	14
Doxycycline Hyclate	Doxycycline Hyclate	32	17
Fenofibrate	Fenofibrate Nanocrystallized	32	11
Terazosin Hcl	Terazosin Hcl	32	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	32	15
Escitalopram Oxalate	Escitalopram Oxalate	31	suppressed
Atrovent Hfa	Ipratropium Bromide	30	suppressed
Glipizide Er	Glipizide	28	suppressed
Hydralazine Hcl	Hydralazine Hcl	28	12
Baclofen	Baclofen	27	suppressed
Duloxetine Hcl	Duloxetine Hcl	27	suppressed
Bupropion Hcl Sr	Bupropion Hcl	26	suppressed
Celecoxib	Celecoxib	25	suppressed
Citalopram Hbr	Citalopram Hydrobromide	25	suppressed
Fluticasone Propionate	Fluticasone Propionate	25	16
Oseltamivir Phosphate	Oseltamivir Phosphate	25	23
Pregabalin	Pregabalin	25	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	25	suppressed
Promethazine Hcl	Promethazine Hcl	24	12
Benazepril Hcl	Benazepril Hcl	22	suppressed
Dropsafe Prep Pads	Alcohol Antiseptic Pads	22	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	22	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	21	15
Ventolin Hfa	Albuterol Sulfate	21	suppressed
Buspirone Hcl	Buspirone Hcl	20	suppressed
Ezetimibe	Ezetimibe	20	suppressed
Glyburide	Glyburide	20	suppressed
Cephalexin	Cephalexin	19	18
Doxazosin Mesylate	Doxazosin Mesylate	19	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	18	suppressed
Glimepiride	Glimepiride	18	suppressed
Ondansetron Hcl	Ondansetron Hcl	18	suppressed
Torsemide	Torsemide	18	suppressed
Febuxostat	Febuxostat	17	suppressed
Betamethasone Diprop Augmented	Betamethasone/Propylene Glyc	16	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	16	suppressed
Tresiba Flextouch U-100	Insulin Degludec	16	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	16	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	15	suppressed
Donepezil Hcl	Donepezil Hcl	15	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	15	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	15	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	15	suppressed
Lovastatin	Lovastatin	15	suppressed
Methimazole	Methimazole	15	suppressed
Topiramate	Topiramate	15	suppressed
Bupropion Xl	Bupropion Hcl	14	suppressed
Calcitonin-Salmon	Calcitonin,salmon,synthetic	14	suppressed
Dulera	Mometasone/Formoterol	14	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	14	suppressed
Klor-Con 10	Potassium Chloride	14	suppressed
Lansoprazole	Lansoprazole	14	suppressed
Levetiracetam	Levetiracetam	14	suppressed
Linzess	Linaclotide	14	suppressed
Xarelto	Rivaroxaban	14	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	13	suppressed
Mupirocin	Mupirocin	13	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	13	suppressed
Verapamil Er	Verapamil Hcl	13	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	13	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	12	suppressed
Clonazepam	Clonazepam	12	suppressed
Ondansetron Odt	Ondansetron	12	suppressed
Propranolol Hcl Er	Propranolol Hcl	12	suppressed
Tizanidine Hcl	Tizanidine Hcl	12	suppressed
Cyproheptadine Hcl	Cyproheptadine Hcl	11	suppressed
Spiriva Handihaler	Tiotropium Bromide	11	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	11	suppressed
Ulticare Pen Needle	Pen Needle, Diabetic	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error